Vimarsana
Biggest News Aggregation in the World

Page 39 - Growth Factor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Growth Factor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Growth Factor Today - Breaking & Trending Today

How SARS-CoV-2 infection progresses throughout the respiratory system - Vimarsana News

How SARS-CoV-2 infection progresses throughout the respiratory system

Researchers discuss the progression of SARS-CoV-2 infection throughout the respiratory epithelium.

The Rising Prevalence Of Cancer Is Driving The Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market In The Forecast Period 2021 2026 - Vimarsana News

The Rising Prevalence Of Cancer Is Driving The Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market In The Forecast Period 2021 2026

The Rising Prevalence Of Cancer Is Driving The Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market In The Forecast Period 2021 2026

The Rising Prevalence Of Cancer Is Driving The Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market In The Forecast Period 2021 2026 - Vimarsana News

The Rising Prevalence Of Cancer Is Driving The Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market In The Forecast Period 2021 2026

The Rising Prevalence Of Cancer Is Driving The Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market In The Forecast Period 2021 2026

Better diagnostic tests needed to guide HER2 breast cancer treatment, study suggests - Vimarsana News

Better diagnostic tests needed to guide HER2 breast cancer treatment, study suggests

A new study by researchers at Yale Cancer Center shows using current standard human epidermal growth factor receptor 2 (HER2) assays as a diagnostic test may result in a mis-assignment of patients for treatment for breast cancer with a promising new drug.

Researchers receive $2,664,522 NIH award to improve long-term functionality of vascular grafts - Vimarsana News

Researchers receive $2,664,522 NIH award to improve long-term functionality of vascular grafts

A graft can be a life-saving device for coronary heart disease, which remains the leading cause of death for both men and women in the United States. However, at small diameters -; such as the coronary artery in the heart -; long-term graft failure rates are often higher than 40 percent.